Johnson Mak

Prof. Johnson Mak

Gold Coast campus, Institute for Glycomics, Griffith University, Brisbane 4222, Australia
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2010 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
MKMaria Kaparakis
Maria Kaparakis
LTLynne Turnbull
Lynne Turnbull
LCLeticia Carneiro
Leticia Carneiro
SFStephen Firth
Stephen Firth
HCHarold A. Coleman
Harold A. Coleman
RFRichard L. Ferrero
Richard L. Ferrero
Gram-negative bacterial peptidoglycan is specifically recognized by the host intracellular sensor NOD1, resulting in the generation of innate immune responses. Although epithelial cells are normally refractory to external stimulation with peptidoglycan, these cells have been shown to respond in a NOD1-dependent manner to Gram-negative pathogens that can either invade or secrete factors into host cells. In the present work, we report that Gram-negative bacteria can deliver peptidoglycan to cytosolic NOD1 in host cells via a novel mechanism involving outer membrane vesicles (OMVs). We purified OMVs from the Gram-negative mucosal pathogens: Helicobacter pylori, Pseudomonas aeruginosa and Neisseria gonorrhoea and demonstrated that these peptidoglycan containing OMVs upregulated NF-κB and NOD1-dependent responses in vitro. These OMVs entered epithelial cells through lipid rafts thereby inducing NOD1-dependent responses in vitro. Moreover, OMVs delivered intragastrically to mice-induced innate and adaptive immune responses via a NOD1-dependent but TLR-independent mechanism. Collectively, our findings identify OMVs as a generalized mechanism whereby Gram-negative bacteria deliver peptidoglycan to cytosolic NOD1. We propose that OMVs released by bacteria in vivo may promote inflammation and pathology in infected hosts.

1 June 2004 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
Jean-Christophe PaillartJean-Christophe Paillart
Jean-Christophe Paillart
MSMiranda Shehu-Xhilaga
Miranda Shehu-Xhilaga
RMRoland Marquet
Roland Marquet
JMJohnson Mak
Johnson Mak

1 October 2001 in Journal of Clinical Virology
Verified
Journal Article
Closed access
SCS.M Campbell
S.M Campbell
SCS.M Crowe
S.M Crowe
JMJohnson Mak
Johnson Mak

13 September 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
PCPaul U. Cameron
Paul U. Cameron
SSSuha Saleh
Suha Saleh
GSGeorgina Sallmann
Georgina Sallmann
ASAjantha Solomon
Ajantha Solomon
FWFiona Wightman
Fiona Wightman
Sharon LewinSharon Lewin
Sharon Lewin
Eradication of HIV-1 with highly active antiretroviral therapy (HAART) is not possible due to the persistence of long-lived, latently infected resting memory CD4 + T cells. We now show that HIV-1 latency can be established in resting CD4 + T cells infected with HIV-1 after exposure to ligands for CCR7 (CCL19), CXCR3 (CXCL9 and CXCL10), and CCR6 (CCL20) but not in unactivated CD4 + T cells. The mechanism did not involve cell activation or significant changes in gene expression, but was associated with rapid dephosphorylation of cofilin and changes in filamentous actin. Incubation with chemokine before infection led to efficient HIV-1 nuclear localization and integration and this was inhibited by the actin stabilizer jasplakinolide. We propose a unique pathway for establishment of latency by direct HIV-1 infection of resting CD4 + T cells during normal chemokine-directed recirculation of CD4 + T cells between blood and tissue.

15 February 2001 in Journal of Virology
Verified
Journal Article
Open access
PDF file
MSMiranda Shehu-Xhilaga
Miranda Shehu-Xhilaga
SCSuzanne M. Crowe
Suzanne M. Crowe
JMJohnson Mak
Johnson Mak
Production of the human immunodeficiency virus type 1 (HIV-1) Gag-Pol precursor protein results from a −1 ribosomal frameshifting event. In infected cells, this generates Gag and Gag-Pol in a ratio that is estimated to be 20:1, a ratio that is conserved among retroviruses. To examine the impact of this ratio on HIV-1 replication and viral assembly, we altered the Gag/Gag-Pol ratio in virus-producing cells by cotransfecting HIV-1 proviral DNA with an HIV-1 Gag-Pol expression vector. Two versions of the Gag-Pol expression vector were used; one contains an active protease [PR(+)], and the other contains an inactive protease [PR(−)]. In an attempt to produce viral particles with Gag/Gag-Pol ratios ranging from 20:21 to 20:1 (wild type), 293T cells were cotransfected with various ratios of wild-type proviral DNA and proviral DNA from either Gag-Pol expression vector. Viral particles derived from cells with altered Gag/Gag-Pol ratios via overexpression of PR(−) Gag-Pol showed a ratio-dependent defect in their virion protein profiles. However, the defects in virion infectivity were independent of the nature of the Gag-Pol expression vector, i.e., PR(+) or PR(−). Based on equivalent input of reverse transcriptase activity, we estimated that HIV-1 infectivity was reduced 250- to 1,000-fold when the Gag/Gag-Pol ratio in the virion-producing cells was altered from 20:1 to 20:21. Although virion RNA packaging was not affected by altering Gag/Gag-Pol ratios, changing the ratio from 20:1 to 20:21 progressively reduced virion RNA dimer stability. The impact of the Gag/Gag-Pol ratio on virion RNA dimerization was amplified when the Gag-Pol PR(−) expression vector was expressed in virion-producing cells. Virions produced from cells expressing Gag and Gag-Pol PR(−) in a 20:21 ratio contained mainly monomeric RNA. Our observations provide the first direct evidence that, in addition to proteolytic processing, the ratio of Gag/Gag-Pol proteins is also important for RNA dimerization and that stable RNA dimers are not required for encapsidation of genomic RNA in HIV-1.

2 July 2014 in Nature Communications
Verified
Journal Article
Closed access
PDF file
EWEkram Abd El- Wahab
Ekram Abd El- Wahab
Redmond Patrick SmythRedmond Patrick Smyth
Redmond Patrick Smyth
EMElodie Mailler
Elodie Mailler
Serena BernacchiSerena Bernacchi
Serena Bernacchi
VVValérie Vivet-Boudou
Valérie Vivet-Boudou
RMRoland Marquet
Roland Marquet